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1ABSTRACT
Cancer-associated fibroblasts regulate gene expression of breast 
cancer cells via exosomal microRNAs
Ji Eun Kim
Department of Medical Science
The Graduate School, Yonsei University
(Directed by Professor Nam Hoon Cho)
Cell-derived vesicles known as exosomes facilitate communication 
between cancer cells and cancer-associated fibroblasts (CAFs). 
CAF-derived molecules, including microRNAs (miRNAs), were 
recently found to be transferred to cancer cells via exosomes. 
However, little is known about the role of CAF-derived exosomal 
miRNAs in tumor progression. To investigate the relationship 
between miRNA levels in fibroblast-derived exosomes and breast 
cancer progression, we analyzed exosomal miRNAs of normal breast 
fibroblasts (NBFs) and CAFs using microarray, examined the delivery 
of exosomal miRNAs from fibroblasts to cancer cells by direct 
exosome treatment, and confirmed the function of exosomal miRNA 
in gene regulation through overexpression. Several miRNAs were 
2downregulated more than two-fold in CAF-derived exosomes, 
compared to NBF-derived exosomes. Endogenous miR-4516, a 
miRNA downregulated five-fold in CAF-derived exosomes, was also 
downregulated in CAF cells. In MCF7 cells, NBF-derived exosomes 
delivered four-fold more miR-4516 than CAF-derived exosomes. 
Overexpression of miR-4516 in MCF7 and MDA-MB-231 cells 
induced downregulation of several tumor progression-associated 
genes (PHF8 and STAT3). Thus, CAFs may regulate gene expression 
in breast cancer cells via exosomal miR-4516. By modulating the 
expression level of miR-4516 in CAF and NBF-derived exosomes, 
breast cancer cells could circumvent the inhibitory effect of exosomal 
miR-4516, promoting tumor progression.
Key words: exosomes, microRNA, cancer-associated fibroblasts, 
tumor microenvironment, breast cancer cells
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I. INTRODUCTION
Cancer-associated fibroblasts (CAFs) are one type of stromal cells 
composing the tumor microenvironment (TME) and have been found to 
build a tumor-preferable microenvironment, such as a dense 
extracellular matrix, and secrete growth factors or cytokines to 
communicate with cancer cells.1,2 At the early stage of tumorigenesis or 
under non-tumorigenic conditions, cancer is suppressed by surrounding 
normal fibroblasts and other stromal components, while CAFs promote 
cancer progression, invasion and migration at the late stages of 
tumorigenesis.3-6 Hence, communication mediators between CAFs and 
4cancer cells have been one of the major issues in cancer research. As 
one CAF-secreted mediator, the exosome carries several molecules, 
including microRNAs (miRNAs), to cancer cells exogenously.7
The exosome is a small 30–100 nm-sized vesicle and a bi-directional 
signaling factor between CAFs and cancer cells.8-10 Secretion of 
exosomes has been observed in various cell types, such as breast cancer 
cells,11 fibroblasts,8 and mesenchymal stem cells.12 Exosomal miRNAs 
are delivered to other cells via exosomes where they are internalized to 
regulate gene expression in recipient cells.13 Valadi and his colleagues 
demonstrated that exosomes enclose miRNAs, as well as proteins and 
mRNAs, which are transferred to other cells and activate their 
functions.10 For example, CD81 positive exosomes, secreted from 
CAFs, activate the Wnt-planar cell polarity signaling pathway to 
promote tumor progression in breast cancer cells.8 Recently, leukemia 
cell-derived exosomal miR-92a was found to be transferred to 
endothelial cells, thereby enhancing endothelial cell tube formation.7
Together, these studies indicate that exosomes may play an important 
role in cell to cell interaction, but the precise role of exosomal miRNA 
in this process is not understood; thus, further study of its role in cancer 
progression is required. MicroRNAs are small non-coding RNAs that 
regulate gene expression at the post-transcriptional level.14,15 It is 
widely accepted that miRNAs play dual roles and act on multiple
targets, allowing them to act as either tumor suppressor genes or 
oncogenes.16 In response to various kinds of extracellular stimulation, 
CAFs endogenously transcribed different types of miRNAs.17,18
5In this study, we demonstrated that breast cancer cells may affect the 
composition of miRNAs organized within CAF-derived exosomes, 
leading to changes in target gene expression in breast cancer cells and 
in the communication between cancer cells and stromal cells. Thus, we 
hypothesized that the differential composition of miRNAs in exosomes 
derived from CAF and normal breast fibroblast (NBF) was responsible
for regulation of gene expression in breast cancer cells. Supporting this 
hypothesis, specific exosomal miRNA was differentially contained 
between CAF and NBF-derived exosomes, and overexpression of 
miRNA in cancer cells suppressed the expression of putative target 
genes required for tumor progression.
6II. MATERIALS AND METHODS
1. Cell culture
CAFs and NBFs were isolated from breast cancer patients undergoing 
surgery at Severance Hospital of the Yonsei University Health System, 
Korea. A pathologist examined and obtained representative samples of 
CAFs and NBFs. A fraction of tissue was used to isolate primary 
fibroblasts as previously described.19,20 Briefly, isolated tissues were 
chopped into small pieces, added to a digestion solution of Enzyme 
Cocktail (ISU ABXIS, Seoul, Korea), and incubated at 37°C in 5% CO2
overnight. Digested tissue was filtered through a 100μm cell strainer 
and suspended in medium:Ficoll (3:2), followed by centrifugation at 
670rpm for 2 minutes. Then, the supernatant containing fibroblasts was 
transferred to a tube and centrifuged at 1,400 rpm for 8 min. The pellet 
was resuspended in Dulbecco’s Modified Eagle Medium (DMEM)/F12 
(1:1) medium (Gibco®, Gaithersburg, MD, USA) supplemented with 
1% penicillin/streptomycin and 20% fetal bovine serum (FBS) 
(Gibco®). Further confirmation of fibroblast characteristics was 
obtained via morphology portrait and immunofluorescence observation 
using antibodies against cytokeratin (Dako, Glostrup, Denmark), 
vimentin (Abcam, Cambridge, UK), and cytokeratin 5 (Novocastra, 
Newcastle upon Tyne, UK). 
Breast cancer cell lines (MDA-MB-231 and MCF7) were cultured in 
DMEM/F12 medium supplemented with 1% penicillin/streptomycin 
and 10% FBS. All cells were cultured at 37°C in 5% CO2. For the 
stimulation of CAFs, the media was changed to MDA-MB-231 
7conditioned medium (231 CM) and incubated for three days. Then, it 
was replaced with 0.5% FBS reduced serum medium (RSM), and 
incubated for two days for exosome preparation.
2. Exosome extraction from cell culture supernatants
NBFs were incubated with RSM for two days and CAFs were prepared 
as described above. The supernatant of NBFs and CAFs was collected 
and centrifuged at 3,000 ×g for 20 min to remove cell debris and 
filtered through a 0.22 μm filter (Nalgene™, Waltham, MA, USA). Due 
to the large volume of supernatant needed, 9kD molecular weight cutoff 
concentrators (Pierce, Rockford, IL USA) were used for 
concentration,21 and the volume was concentrated to 10 ml, according 
to the manufacturer’s protocol. The appropriate volume of 
ExoQuick-TC™ (System Bioscience, Mountain View, CA, USA) was 
added to the concentrated medium. After overnight incubation at 4°C, 
the mixture was centrifuged at 3,500 ×g for 30 min and the supernatant 
was removed by aspiration. Exosome pellets were suspended with a 
large volume of phosphate buffered saline (PBS) and centrifuged again. 
The supernatant was aspirated, and the exosome pellet was resuspended 
with serum-free DMEM/F12 (1:1) medium supplemented with 1% 
penicillin/streptomycin for further experiments. 
3. Flow cytometry
For fluorescence-activated cell sorting (FACS) analysis, exosomes were 
prepared as described with minor modifications.22,23 Briefly, exosomes
were incubated with 4 μm aldehyde/sulfate latex beads (Invitrogen®, 
Carlsbad, CA, USA) overnight at room temperature in PBS with gentle 
8agitation. After centrifugation, exosome-coated beads were blocked by 
100mM glycine for 1 hr. They were washed twice with PBS and 
resuspended with incubation buffer (PBS/0.5% (w/v) BSA). They were 
then incubated with PE mouse anti-human CD63 antibody (BD 
Pharmingen™, San Diego, CA, USA) or PE mouse IgG1, κ Isotype 
control antibody (BD Pharmingen™) for 2 hr at room temperature in 
the dark. Exosome-coated beads were analyzed by flow cytometry, 
using a FACSVerse (BD Biosciences, San Jose, CA, USA).
4. MiRNA Stem-Loop Real-Time polymerase chain reaction 
(qRT-PCR)
Total RNAs from CAF and NBF-derived exosomes, fibroblasts, and
cancer cells were extracted by TRIzol RNA isolation reagent 
(Ambion®, Grand Island, NY, USA). RNA concentration was 
examined by ND-2000/2000c (NanoDrop Technologies Inc., 
Wilmington, DE, USA). To determine the endogenous level of 
miR-4516 in NBFs and CAFs, qRT-PCR was performed. A cDNA 
synthesis kit was used for reverse transcription (Enzinomics, Dae-jun, 
South Korea). Due to the short length of the miRNA, stem-loop cDNA 
synthesis was necessary as previously described.24 Briefly, 1 μg of total 
RNA and 1 μl miR-4516 RT primer was prepared in a total volume of 
20 μl. Reverse transcriptase reactions were performed in Veriti 
Thermocycler (Applied Biosystems®, Grand Island, NY, USA) for 30 
min at 16°C, 30 min at 42°C and for 5 min at 85°C. Power SYBR®
Green PCR Master Mix (Applied Biosystems®) was used for 
StepOnePlus™ qRT-PCR (Applied Biosystems®). Briefly, 1 μl cDNA 
was mixed with Power SYBR® Green PCR Master Mix, and universal 
9and miRNA primers in a total volume of 25 μl, according to the 
manufacturer’s recommendations. The reactions were run in triplicate 
and the relative expression of intracellular miR-4516 was calculated 
with delta-delta Ct methods after normalization to 18S rRNA. The 
following PCR primers were used: miR-4516 RT primer: 5’-
GTCGTATCCAGTGCAGGGTCCGAGGTATTCGCACTGGATACGA
CGCCCCG-3’, universal primer: 
5’-CCAGTGCAGGGTCCGAGGTA-3’, miR-4516 primer: 
5’-CAGAACGGGAGAAGGGTCGG-3’, 18S rRNA forward primer: 
5′-GTAACCCGTTGAACCCCATT-3′ and reverse primer: 
5′-CCATCCAATCGGTAGTAGCG-3′. 
5. Transfer of exosomal miRNA
MCF7 cells were seeded in a 6-well plate prior to initiation of the 
experiment. When MCF7 cells were approximately 70% confluent, 
previously isolated CAF and NBF-derived exosomes suspended with 
serum-free DMEM/F12 (1:1) medium supplemented with 1% 
penicillin/streptomycin were directly added to each well. MCF7 cells 
were harvested after two days of incubation at 37°C in 5% CO2. To 
analyze the amount of exosomal miR-4516 that was absorbed by 
MDA-MB-231 and MCF7 cells, total RNA from breast cancer cells 
was isolated as described above and qRT-PCR for miR-4516 and 
control 18S rRNA was performed. Relative expression of miR-4516 
was measured by delta-delta Ct values and cells treated with 
CAF-derived exosomes were compared to cells treated with 
NBF-derived exosomes. 
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6. Transfection of MDA-MB-231 and MCF7 cells with mature 
miR-4516
MiR-4516 sequence was inserted into pENTR™/H1/TO vector 
(Invitrogen™). Two hours before transfection, medium in each well 
was changed to Opti-MEM medium (Gibco®). Lipofectamine® 
transfection reagent (Life Technologies, Grand Island, NY, USA) was 
used to transfect miR-4516 into MDA-MB-231 and MCF7 cells. The 
day after transfection, the medium was changed to fresh serum-free 
DMEM (Gibco®). After incubation for two days, the cells were 
harvested, followed by reverse transcription-PCR (RT-PCR) via the 
AmpONE™ kit (GeneAll, Seoul, South Korea). The following PCR 
primers were used:  PHF8 primers forward: 
5’-GGCTGCTGACATTGACCTCT-3’ and reverse: 
5’-CATGCCCAACCCATCCTTCT-3’, STAT3 primers forward: 
5’-ACCAGCAGTATAGCCGCTTC-3’ and reverse: 
5’-AGGCGTGATTCTTCCCACAG-3’.
7. Western blotting 
For western blot analysis, proteins in cells were extracted using a 
PRO-PREP™ kit (iNtRON Biotechnology, Seoul, South Korea) and 
the concentration of proteins was determined using a Bradford method. 
Equal amounts of protein from cells were separated on SDS-PAGE gels 
(Life Technologies) and blotted onto PVDF membranes (Millipore, 
Billerica, MA, USA). Western blots were incubated with antibodies 
directed against PHF8 (1:2,000; Santa Cruz Biotechnology, Inc., CA, 
USA), STAT3 (1:2,000, Santa Cruz), and ß-actin (1:2,000; Santa Cruz), 
followed by probed with HRP-tagged secondary antibodies (1:10,000; 
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Invitrogen® and GenDEPOT, Barker, Texas, USA). The 
Protein-antibody complexes were developed using a luminol reagent 
(Santa Cruz). 
8. MiRNA microarray and profiling
MiRNA microarray was performed by NanoString nCounter® miRNA 
expression assay (NanoString Technologies, Inc. Seattle, WA, USA). 
Each CAF- and NBF-derived exosome was collected continuously via 
ExoQuick-TC™ (System Bioscience) until appropriate amounts of 
exosome pellets were accumulated. We requested the miRNA 
microarray with isolated total RNAs from exosomes. The entire process 
was performed by the PhileKorea Company. 
9. Tissue acquisition. 
For the isolation of CAFs and NBFs, human breast cancer tissues were 
extracted from three IDC patients. The tissues were donated by patients 
who underwent surgery at Severance Hospital of the Yonsei University 
Health System, Seoul, South Korea. The protocol for the research was 
approved by the Severance Hospital Ethics Committee (IRB number 
4-2008-0383). All patients agreed and signed the consent forms and 
were informed of the usage of their tissues for comprehensive 
experiments of breast cancer.
10. Statistical analysis
Two treatment groups were compared using the Mann–Whitney U-test 
or Student’s t-test. Multiple group comparisons were done by one-way 
12
ANOVA. For statistical analysis, GraphPad Prism 6 (GraphPad 
Software, Inc. La Jolla, CA) for Windows was used. Results were 
considered statistically significant when P < 0.05.
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III. RESULTS
1. Characterization of exosomes derived from CAFs
To confirm that exosomes were correctly collected from the supernatant 
of fibroblasts (Figure 1), exosome pellets were analyzed by flow 
cytometry with phycoerythrin (PE)-conjugated CD63 antibody, a 
widely known exosome marker,10 or an isotype control antibody 
(Figure 2A). For further validation, exosomal RNAs were compared 
with total RNAs from fibroblast cell lysates. Total RNA extracted from 
the fibroblast cell lysate showed clear peaks representing 28S (5 kb) 
and 18S (2 kb) rRNAs, and the 28S/18S ratio was 2.3, which indicated 
intact total RNAs. On the other hand, the RNAs isolated from 
CAF-derived exosomes contained almost no 28S and 18S rRNAs and 
relatively small sized RNAs were detected (Figure 2B).
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Figure 1. Exosome isolation process. CAFs were treated with 
MDA-MB-231 conditioned medium (231 CM) or MCF7 CM for three 
days, followed by replacement with 0.5% FBS reduced serum medium 
(RSM), and incubation for two days. NBFs were just incubated with 
RSM for two days. The supernatant from CAFs or NBFs was collected 
and concentrated using a spin column concentrator. ExoQuick-TC™ 
was added, and then samples were refrigerated overnight and 
centrifuged to obtain the exosome pellet, which was used for further 
analysis. 
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Figure 2. Detection of exosomes isolated from supernatants of 
fibroblasts grown in cell culture. (A) For FACS analysis of supernatant, 
the blue area represents the isotype control, while the red area indicates 
PE-positive CD63 conjugated exosome-coated beads. CD63 is used as 
a marker for exosomes. (B) Total RNAs were extracted from 
CAF-derived exosomes and CAF cell lysate and analyzed by a
fragment analyzer. RNAs from CAF cell lysate showed clear peaks of 
28S and 18S rRNAs, indicating intact RNAs. However, RNAs from 
CAF-derived exosomes showed no 28S or 18S rRNA, and, instead, 
relatively small RNAs were detected.
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2. Comparative analysis of CAF- and NBF-derived exosomal 
miRNAs
To demonstrate the different exosomal contents of CAF- and 
NBF-derived exosomes, exosomal miRNAs were analyzed using 
microarray. Among 800 miRNAs in the microarray platform, most were 
expressed at low levels or showed little change between CAF- and 
NBF-derived exosomal miRNAs (Figure 3A). Ten miRNAs 
(miR-132-3p, miR-199b-5p, miR-555, miR-99a-5p, miR-720, 
miR-222-3p, miR-92a-3p, miR-323a-5p, miR-744-5p, and 
miR-18b-5p) increased by at least 1.7-fold in CAF-derived exosomes 
compared to exosomes derived from NBFs. Conversely, thirteen 
miRNAs (miR-451a, miR-630, miR-187-3p, miR-142-3p, 
miR-371b-3p, miR-136-5p, miR-1284, miR-29b-3p, miR-1253, 
miR-1915-3p, miR-144-3p, miR-320e, and miR-4516) decrease by at 
least 1.7-fold in CAF-derived exosomes compared to NBF-derived 
exosomes (Figure 3B). 
As shown in Table 1, miR-29b-3p, miR-1253, and miR-1915-3p 
showed approximately two-fold expression changes between CAF- and 
NBF-derived exosomes, while miR-144-3p and miR-320e showed 
about three-fold changes. MiR-4516 expression in CAF-derived 
exosomes was highly downregulated compared to NBF-derived 
exosomes (Table 1). In fact, miR-4516 showed a five-fold change, 
which was the largest relative change detected in the microarray result. 
In addition, miR-132-3p and miR-199b-5p were both upregulated 
two-fold in CAF-derived exosomes compared to NBF-derived 
exosomes (Table 2).
17
Figure 3. Comparative analysis of miRNAs in CAF- and NBF-derived 
exosomes. (A) A heat map comparing the expression of eight hundred 
microRNAs in the microarray platform in CAF-derived exosomes to 
the expression in NBF-derived exosomes. (B) Twenty-three miRNAs 
showed at least a 1.7-fold change in expression between CAF-derived 
and NBF-derived exosomal microRNAs. Thirteen of these miRNAs 
(miR-451a, miR-630, miR-187-3p, miR-142-3p, miR-371b-3p, 
miR-136-5p, miR-1284, miR-29b-3p, miR-1253, miR-1915-3p, 
miR-144-3p, miR-320e, and miR-4516) showed decreased expression 
18
in CAF-derived exosomes compared to NBF-derived exosomes.
Table 1. Downregulated miRNAs in CAF-derived exosomes
microRNA
CAF-derived 
exosome expression
NBF-derived 
exosome expression
Fold    
Change
hsa-miR-4516 22.89 118.46 -5.18
hsa-miR-320e 36.5 136.51 -3.74
hsa-miR-144-3p 21.68 67.9 -3.13
hsa-miR-1915-3p 15.01 41.17 -2.74
hsa-miR-1253 2.65 5.95 -2.25
hsa-miR-29b-3p 251.34 556.86 -2.22
hsa-miR-1284 9.32 18.33 -1.97
hsa-miR-136-5p 17.27 33.44 -1.94
hsa-miR-371b-3p 8.84 16.09 -1.82
hsa-miR-142-3p 30.51 54.65 -1.79
hsa-miR-187-3p 22.18 39.33 -1.77
hsa-miR-630 51.89 91.56 -1.76
hsa-miR-451a 626.42 1068.44 -1.71
hsa-miR-155-5p 7.7 12.8 -1.66
hsa-miR-184 10.64 17.29 -1.63
hsa-miR-203 16.3 26.25 -1.61
hsa-miR-21-5p 215.13 346.01 -1.61
hsa-miR-543 25.69 40.91 -1.59
hsa-miR-765 9.88 15.38 -1.56
hsa-miR-636 8.21 12.46 -1.52
Six microRNAs (with fold changes indicated in bold) showed the most 
decrease in CAF-derived exosomes. The most negatively changed 
miRNA was miR-4516 with -5.18-fold change. MiR-144-3p, miR-320e, 
and miR-4516 were detected at low levels in CAF-derived exosomes. 
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Table 2. Upregulated miRNAs in CAF-derived exosomes
microRNA
CAF-derived 
exosome expression
NBF-derived 
exosome expression
Fold    
Change
hsa-miR-132-3p 86.14 33.32 2.59
hsa-miR-199b-5p 83.75 35.34 2.37
hsa-miR-555 9.51 5.2 1.83
hsa-miR-99a-5p 43.32 23.61 1.83
hsa-miR-720 49.73 27.26 1.82
hsa-miR-222-3p 197.77 110.8 1.78
hsa-miR-92a-3p 25.18 14.41 1.75
hsa-miR-323a-5p 16.59 9.59 1.73
hsa-miR-744-5p 28.8 16.7 1.72
hsa-miR-18b-5p 21.82 12.75 1.71
hsa-miR-1225-3p 16.5 9.74 1.69
hsa-miR-296-3p 11.46 6.77 1.69
hsa-miR-520g 14.7 8.79 1.67
hsa-miR-490-3p 18.53 11.46 1.62
hsa-miR-582-3p 20.18 12.49 1.62
hsa-miR-30d-5p 25.93 16.11 1.61
hsa-miR-199a-5p 54.53 34.11 1.6
hsa-miR-548ag 24.46 15.3 1.6
hsa-miR-1224-3p 9.43 5.94 1.59
hsa-miR-1267 16.63 10.51 1.58
MicroRNAs upregulated at least two-fold in CAF-derived exosomes 
compared to NBF-derived exosomes. MiR-132-3p and miR-199b-5p 
showed the greatest change between CAF- and NBF-derived exosomes.
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3. Downregulation of endogenous expression of miR-4516 in CAFs 
and NBFs stimulated with 231 CM
To confirm whether CAFs expressed less endogenous miR-4516 
compared to NBFs, as was the case with exosomes derived from these 
cells, and to determine whether heterogeneous cancer stimulation 
would influence miRNA expression changes in CAFs, the expression 
level of miR-4516 in CAFs was determined upon stimulation with 
cancer-conditioned medium and compared to NBFs. Both 231 CM and 
MCF7-conditioned medium (MCF7 CM) were used to stimulate CAFs 
and observe the difference in miR-4516 expression. These two cancer 
cells were chosen to represent the influence of different levels of 
invasiveness on CAFs, as MDA-MB-231 cells are known to be more 
invasive than MCF7 cells.25 CAFs treated with 231 CM showed a 
significant decrease of endogenous miR-4516 compared to control 
NBFs (Figure 4A). Although CAFs treated with MCF7 CM showed a 
similar tendency of decreased miR-4516 expression upon treatment, the 
change was not significant (Figure 4B).
To determine whether cancer stimulation would cause NBFs to exhibit 
CAF-like behavior such as a decrease of endogenous miR-4516, NBFs 
were treated with 231 CM for a total of four days. The endogenous 
level of miR-4516 was measured by qRT-PCR daily (Figure 4C). Like 
CAFs, NBFs stimulated by 231 CM showed reduced levels of 
miR-4516. At day 1, approximately a half-fold downregulation of 
miR-4516 was observed, and after three days, miR-4516 expression 
decreased continuously in 231 CM treated NBFs compared to the 
21
control non-treated NBFs. NBFs showed the significant decrease of 
cellular miR-4516 levels over the four days of CM treatment.
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4. Transfer of exosomal miR-4516 to breast cancer cells
To investigate the effect of CAF-derived exosomes containing reduced 
levels of miR-4516 on cancer cells, MCF7 and MDA-MB-231 cells 
were directly treated with CAF- or NBF-derived exosomes. MCF7 cells 
were incubated with CAF- or NBF- derived exosomes for two days, 
and the miR-4516 level was quantified by qRT-PCR. MCF7 cells 
treated with CAF-derived exosomes showed an insignificance of 
endogenous miR-4516 levels compared to untreated mock MCF7 cells. 
On the other hand, compared to MCF7 cells treated with NBF-derived 
exosomes, containing high levels of miR-4516, miR-4516 expression 
significantly decreased more than four-fold in cells treated with 
CAF-derived exosomes (Figure 4D). Like MCF7 cells, low levels of 
miR-4516 were observed in MDA-MB-231 cells treated with 
CAF-derived exosomes and untreated mock MDA-MB-231 cells. 
When MDA-MB-231 cells incubated with CAF-derived exosomes 
were compared to the cells with NBF-derived exosomes, they also 
showed a decrease of endogenous miR-4516 (Figure 4E).
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Figure 4. Changed expression of miR-4516 in CAFs and NBFs upon 
231 CM stimulation and transfer of miR-4516 to breast cancer cells via 
exosomes. (A) Box- Whisker plot displays the level of miR-4516 in 
231-CM treated CAF and non-treated control NBF. The horizontal line 
into the boxes indicates the median, and the bars define the 10th and 
the 90th percentiles. Upon 231 CM stimulations, endogenous 
miR-4516 expression was significantly downregulated in CAFs (***P 
< 0.001) compared to control NBF cells without 231 CM treatment. (B) 
Box- Whisker plot displays the level of miR-4516 in MCF7 CM treated 
CAF and non-treated control NBF. The horizontal line into the boxes 
indicates the median, and the bars define the 10th and the 90th 
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percentiles. MCF7 CM-stimulated CAFs showed no significant change 
in endogenous miR-4516 expression compared to control NBF cells 
without MCF7 CM treatment. MiR-4516 expression level was analyzed 
by using qRT-PCR in triplicate and relative expression was calculated 
using the delta-delta Ct method. P-values were determined using the 
Mann–Whitney test. (C) During four days, the expression of miR-4516 
was analyzed daily by qRT-PCR. NBFs stimulated with 231 CM 
showed continuous decrease of miR-4516 levels (*P < 0.05) compared 
with control NBFs without treatment of 231 CM. The values are 
presented as the mean±SD; n = 3 for each group. P-values were 
determined using an unpaired two-tailed Student’s t-test. (D) MCF7 
cells were incubated with either CAF- or NBF-derived exosomes, while 
mock MCF7 cells were treated with RSM. Compared to the cells with 
NBF-derived exosomes, MCF7 cells incubated with CAF-derived 
exosomes showed a significant decrease in miR-4516 level (***P < 
0.001). Meanwhile, MCF7 cells with CAF-derived exosomes showed 
insignificance compared to mock MCF7 cells. (E) MDA-MB-231 cells 
showed a decrease of miR-4516 levels upon treatment with 
CAF-derived exosomes compared to treatment with NBF-derived cells 
(*P < 0.05). MDA-MB-231 cells with CAF-derived exosomes, however, 
showed insignificance compared to mock MDA-MB-231 cells with 
RSM. MiR-4516 expression level was analyzed, using qRT-PCR in 
triplicate. The values are presented as the mean±SD; n = 3 for each 
group. P-values were determined using one-way anova.
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5. Regulation of tumor progression-related genes in miR-4516 
overexpressed breast cancer cells
Putative target genes of miR-4516 was analyzed with the miRNA target 
gene prediction database TARGETSCAN26 (http://www.targetscan.org),
cancer-associated gene database GeneCards27 (www.genecards.org), 
The Biological General Repository for Interaction Datasets28
(BioGRID: http://thebiogrid.org) and STRING ver. 10 database29
(http:// http://string-db.org). A total of 9,332 genes were categorized as 
cancer-associated genes and 2,193 genes were found as oncogenes, 
while total of 114 genes were predicted for miR-4516 putative target 
genes. 2,085 genes were showed for cancer-associated and oncogenic 
genes and 46 genes were predicted as both cancer-associated and 
miR-4516 putative target genes. After comparing the target genes 
predicted by two algorithms and overlapped sections, a consensus list 
of 23 putative target genes was common between them (Figure 5A). 
The overlapped section of miR-4516 putative genes and oncogenes was 
also showed exactly the same gene list with 23 putative genes common 
in all three parts. Among 23 common genes (predicted), Plant 
homeodomain finger protein 8 (PHF8) and signal transducer and 
activator of transcription 3 (STAT3) genes were located. PHF8 was 
ranked at the highest, while STAT3 was listed at 8th. PHF8 was chosen 
for its favorable context+ score, which is the sum of six features of 
contribution for specific target sites and STAT3 was focused since the 
recent study found its direct binding and interaction between STAT3 
and miR-4516. These genes indicated as oncogenic cancer-associated 
miR-4516 target genes. 
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After sorting a few putative target genes out, several genes were found 
for their possible interaction with target genes based on the BioGRID 
database. Four characteristics of cancer progression were categorized: 
invasion, migration, proliferation and epithelial-mesenchymal transition 
(EMT). All genes under each category were overlapped in BioGrid and 
GeneCards database. Additionally, the interactions between all 23 
putative target genes were analyzed by STRING database (Figure 5B).
It showed that PHF8 and STAT3 could be interactive through HCFC1 
and SP1.
To investigate whether decreased exosomal miR-4516 could influence 
tumor progression-related genes in breast cancer cells, MCF7 and 
MDA-MB-231 cells were transfected with a miR-4516-containing 
pENTR™/H1/TO vector. Overexpression of miR-4516 in cancer cells 
represented transferring NBF-derived exosomes to cancer, while cells 
transfected with control vector mimicked the condition of transferring 
CAF-derived exosomes. Overexpression of miR-4516 in breast cancer 
cells were confirmed by RT-PCR and then, expressions of PHF8 and 
STAT3 were determined by RT-PCR with 18s rRNA control. When 
miR-4516 was overexpressed in MCF7 cells, all levels of PHF8 and 
STAT3 were decreased. In MDA-MB-231 transfected with miR-4516, 
expressions of both PHF8 and STAT3 showed downregulated compared 
to cells transfected with control vector (Figure 5C). 
Protein expression in MCF7 and MDA-MB-231 cells transfected with 
miR-4516 was determined. Both cells were confirmed their miR-4516 
overexpression beforehand by RT-PCR. Compared to MCF7 cells 
transfected with control vector, PHF8 and STAT3 protein expression 
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levels were repressed in MCF7 cells transfected with miR-4516 vector. 
In the case of MDA-MB-231, PHF8 and STAT3 expressions were also 
decreased when miR-4516 was overexpressed in the cells (Figure 5D). 
Thus, as miR-4516 overwhelmed the breast cancer cells, expression of 
putative target genes was inhibited. 
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Figure 5. Selection of miR-4516 putative target genes and decreased 
expression in MCF7 and MDA-MB-231 cells overexpressing 
miR-4516. (A) Venn diagram illustrating miR-4516 putative target 
genes predicted by Target Scan and analyzed with GeneCards database. 
There were 23 genes were predicted as the common genes for 
oncogenic, cancer-associated as well as miR-4516 putative target genes. 
The listed genes in the overlapped part of miR-4516 putative target 
genes and oncogenes were identical to the genes in overlapped in triple 
overlapped section. PHF8 was ranked 1st place for its favorable 
prediction score and STAT3 was listed at 8th. (B) By BioGRID and 
GeneCards database, several genes were found as that they could relate 
to cancer progression (invasion, migration, proliferation, and EMT) as 
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well as possibly interact with miR-4516 target genes. The possible 
interactions of 23 putative target genes and other genes were 
established by STRING database. (C) Expression of putative target 
genes of miR-4516 was analyzed by RT-PCR. The plus sign (+) 
represented overexpression of miR-4516 by transfection and the minus 
sign (-) represented transfection with the control vector. Both MCF7 
cells and MDA-MB-231 cells transfected with miR-4516 vector 
showed decreased expression of PHF8 and STAT3 compared to the 
control. (D) Expression of putative target genes of miR-4516 was 
analyzed by western blotting. The plus sign (+) represented 
overexpression of miR-4516 and the minus sign (-) represented 
transfection with the control vector. All overexpression level was 
previously confirmed by RT-PCR and then, further protein validation 
was preceded. Compared to MCF7 and MDA-MB-231 cells transfected 
with miR-4516 vector, cells transfected with control vector showed 
higher expression in PHF8 and STAT3.
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Figure 6. Suggestive model for the communication between CAFs and 
breast cancer cells via exosomes. (1) At an early stage of tumorigenesis, 
NBFs could surround the single-cell unit cancer cells, suppressing 
tumor expansion. (2) They may communicate with cancer cells via 
secretory exosomes containing high levels of miR-4516. NBF-derived 
exosomal miR-4516 could inhibit certain genes associated with tumor 
progression in breast cancer. However, (3) cancers continuously 
stimulate CAFs during cancer progression; they could start 
accumulating around the tumor and the environment becomes favorable 
to cancer cells. CAFs also secrete exosomes, but the miRNA contents 
could be different that NBF-derived exosomes. CAFs have decreased 
cellular expression of miR-4516, and CAF-derived exosomes could 
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contain reduced amounts of miR-4516. (4) The downregulation of 
miR-4516, due to the increased presence of CAFs and CAF-derived 
exosomes could lead to decreased inhibition of tumor 
progression-related genes in cancer cells. (5) Therefore, the suppression 
of putative target genes, including PHF8 and STAT3 by miR-4516
could be weakened and they could play an important role in breast 
cancer progression.
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IV. DISCUSSION
In TME, CAFs are located within or around the tumor mass and are 
simultaneously influenced by direct cancer cell contact and 
cancer-secreting factors.1 CAFs can communicate with cancer cells via 
exosomes and their contents, such as miRNAs, could act as endogenous 
genes in cancer cells.10 CAFs may compose exosomal miRNA contents 
in different ratios so that they could influence gene expression 
associated with tumor progression by transferring upregulated or 
downregulated exosomal miRNAs. Reduced levels of certain exosomal 
miRNAs could be advantageous to cancers since the inhibitory effects 
suppressing tumor progression could be alleviated in cancer cells.
Prior to this study, the role of miR-4516 in cancer had not been studied 
aggressively and also, upregulated miRNAs were not as significant as 
downregulated miRNAs based on microRNA microarray. qRT-PCR for 
other two to three-fold upregulated or downregulated microRNAs in 
CAF-derived exosomes compared to NFB-derived exosomes were 
performed, however, not significant expression changes were found 
(data not shown), except for miR-4516. This, along with its five-fold 
decrease in CAF-derived exosomes compared to NBF-derived 
exosomes, made it an attractive target for further study. Therefore, we 
focused on investigating whether exosomal miR-4516 in CAF-derived 
exosomes could regulate gene expression in breast cancer cells, 
affecting tumor progression (Figure 3).
231 CM or MCF7 CM was used to compare the influence of 
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heterogeneous breast cancer cells on CAFs as well as stimulating NBFs 
to exhibit CAF-like features. 231 CM-treated CAFs showed a 
significant decrease of miR-4516 compared to control cells, while 
MCF7 CM treated CAFs did not show significant changes. These 
results suggest that in a heterogeneous situation, more invasive breast 
cancer cells could have a larger influence on CAFs compared to less 
invasive cancer cells. MDA-MB-231 cells induced significant changes 
in miRNA levels, indicating that exosomes from 231 CM-stimulated 
CAFs may help regulate gene expression of breast cancer cells more 
effectively. Moreover, they could indirectly compensate for minor 
stimulation by less invasive cells (Figure 4A and B).
At the early stages of tumorigenesis, cancer cells could be suppressed 
by the uptake of excessive exosomal miR-4516 from NBF-derived 
exosomes. However, as cancers expand, they could constantly stimulate 
normal fibroblasts, causing them to adopt CAF-like features, such as a 
decrease in cellular miR-4516 levels. As NBFs underwent 231 CM 
stimulation, the significant decrease of miR-4516 expression we 
observed could explain how cancer might influence fibroblasts 
indirectly to downregulate tumor suppressing miRNA expression. Thus, 
the decrease in exosomal miRNA in CAF-derived exosomes and 
cancers can lead to decreased inhibitory effects and regulate gene 
expression in breast cancer (Figure 4C). 
Both MCF7 and MDA-MB-231 breast cancer cells were used as 
recipient cells since NBF- and CAF-derived exosomes could influence 
to the heterogeneous breast tumors. Both MCF7 and MDA-MB-231 
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cells incubated with CAF-derived exosomes showed a significant 
decrease of cellular miR-4516 levels, while an increase was shown 
upon treatment with NBF-derived exosomes compared to control 
(Figure 4D and E). Similar to microarray results, breast cancer cells 
treated with CAF-derived exosomes showed significant suppression of 
endogenous miR-4516 compared to cells treated with NBF-derived 
exosomes. Together, these results indicate that the level of miR-4516 in 
exosomes was determined by the type of fibroblast from which it was 
derived: CAFs or NBFs. Like MCF7 cells, MDA-MB-231 cells treated 
with CAF-derived exosomes showed a downregulation of miR-4516 
compared to control cells. Moreover, MCF7 cells treated with 
CAF-derived exosomes downregulated miR-4516 levels about 
four-fold, while the level in MDA-MB-231 cells also decreased 
compared to cells with NBF-derived exosomes. To explain the different 
level of absorption between MCF7 and MDA-MB-231, we determined 
that endogenous miR-4516 expression levels were higher in 
MDA-MB-231 cells than MCF7 cells (data not shown). Thus, it is 
possible that absorbed exosomal miRNA in MDA-MB-231 cells may 
be less dramatic than in MCF7 cells. 
PHF8 and STAT3 were found by overlapping in three venn diagram. 
They could be thought as oncogenic cancer associated miR-4516 target 
genes (Figure 5A). PHF8 presented the most favorable (lowest) context 
score+ by TargetScan prediction database and was also related to 
cancer progression, affecting cell proliferation and invasion in prostate 
cancer.30 In recent studies, a relationship was established between 
miR-4516 and STAT3 in human keratinocytes with or without PUVA 
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treatment, and miR-4516 was found to bind to the STAT3 3’UTR, 
downregulating its expression.31 Activation of STAT3 could also 
promote breast cancer cell migration via mediating upregulation of 
autotaxin.32 Taken together, those four genes were selected in this 
research to show that miR-4516 target genes could be associated with 
breast tumor progression and overexpression of miR-4516 could 
suppress their expression. 
As Figure 5B showed, when miR-4516 could inhibit the target genes, 
several genes that could interact with miR-4516 target genes and relate 
to tumor progression would be suppressed. By BioGrid and GeneCards
database analysis, four features of cancer progression were established: 
invasion, migration, proliferation and EMT. When miR-4516 inhibits 
target oncogenic genes, possible interaction with other genes associated 
with possible tumor progression could be influenced like a 
chain-reaction, thus, cancer progression could be abated. Meanwhile, 
less miR-4516 exists, less inhibitory effect influences to cancer cells. 
The interaction between miR-4516 putative target genes was 
established on a basis of STRING database. PHF8 and STAT3 could 
communicate through interacting SP1 and HCFC1, which have been 
known for their association with tumor progression.33,34
Overexpression of miR-4516 in breast cancer cells represented cells 
influenced by NBF-derived exosomes at an early stage of cancer. Since 
NBF-derived exosomes carried a high level of miR-4516, cancer cells 
which absorb NBF-derived exosomes would be suppressed by 
exosomal miR-4516 during early tumorigenesis. Conversely, control 
36
cells represented cells influenced by CAF-derived exosomes, which 
carried less miR-4516. Comparing these cells explained the roles of 
miR-4516 and the advantages of low miRNA levels to breast cancer 
cells (Figure 5C). By RT-PCR, overexpression of miR-4516 was 
confirmed as well as four putative target mRNA level changes. When 
miR-4516 overexpressed, expression levels of PHF8 and STAT3 were 
downregulated compared to control in both MCF7 and MDA-MB-231, 
which suggested that miR-4516 would influence these genes 
expression. 
Western blot was performed to convince the possible relationship 
between miR-4516 and putative target genes. As miR-4516 was 
overexpressed in MCF7 and MDA-MB-231, target protein levels were 
decreased (Figure 5D) and it could be interpreted as the inhibitory 
effect of miR-4516 in breast cancer cells. When CAFs secrete 
exosomes with less amounts of miR-4516 within to recipient cancer 
cells, cancer could evade influence of miR-4516 and its target genes 
could function actively, which finally cancer progression proceed. 
As miR-4516 overwhelmed the breast cancer cells, expression of 
putative target genes associated with tumor progression could be 
inhibited. Thus, the decrease in exosomal miRNA in CAF-derived 
exosomes and cancers could lead to decreased inhibitory effects and 
regulate gene expression in breast cancer. Determining the direct 
interaction of miRNA and each target gene, and the roles of these target 
genes in breast cancer cells will be the subject of future studies. 
In summary, this study demonstrated that miRNA contents differed in 
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exosomes from CAF and NBFs. Exosomes containing different level of 
exosomal miR-4516 could be transferred into cells, and they influenced 
tumor progression-related genes in breast cancer cells. Significant 
downregulation of endogenous miR-4516 in CAFs could be driven by 
communication with cancer cells, and NBFs stimulated with cancer 
CM demonstrated CAF-like features such as decreasing miR-4516. 
Moreover, direct treatment of cancer cells with CAF- or NBF-derived 
exosomes demonstrated the influence of exogenous exosomal miRNA 
in cancer cells. To interact with cancer cells, CAFs secreted exosomes, 
containing less miR-4516 than NBFs, ensuring that breast cancer cells 
would not be influenced by exosomal miR-4516 as much as they were 
at early stages of cancer. This is the first research to suggest that CAFs 
may contain different exosomal miRNA contents than NBFs and that 
exosomal miR-4516 derived from CAFs may regulate tumor 
progression-related genes in breast cancer cells (Figure 6).
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V. CONCLUSION
In conclusion, the genes associated with tumor progression could 
ultimately be regulated via reduced influx of exosomal miR-4516 from 
CAFs in breast cancer cells. Putative target genes, which have been 
suppressed by miRNA, could be highly expressed, leading to tumor 
progression. Our study suggests that exosomal miR-4516 may be 
positively used as an anti-tumor therapy.
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ABSTRACT (IN KOREAN)
엑소좀 마이크로RNA를 통한 암-연관 섬유아세포의 유방암
유전자 발현 조절
<지도교수 조 남 훈>
연세대학교 대학원 의과학과
김 지 은
암-연관 섬유아세포는 종양미세환경을 이루는 세포 중
하나로서 엑소좀과 같은 분비 인자들을 통하여 유방암과
소통한다. 암-연관 섬유아세포가 mRNA, 마이크로RNA, 
단백질을 담고 있는 엑소좀을 통하여 유방암세포 진행에
영향을 준다는 연구가 활발히 진행되고 있지만 유방암에
미치는 암-연관 섬유아세포가 분비하는 엑소좀 유래
마이크로RNA에 대한 연구가 많지 않아 이에 중점을 두고
연구를 진행하게 되었다. 정상 유방 섬유아세포와 암-연관
섬유아세포가 분비하는 엑소좀 내 마이크로RNA 구성 변화와
특정 엑소좀 마이크로RNA가 유방암세포에 미치는 영향을
밝히기 위해 정상 유방 섬유아세포와 암-연관 섬유아세포에서
각각 추출한 엑소좀 내 마이크로RNA 종류 및 발현을
비교하였다. 그 결과, 정상 유방 섬유아세포와 비교하여
45
암-연관 섬유아세포 유래 엑소좀에서 miR-4516의 발현량이 약
5배 감소되어 존재함이 분석되었다. 침윤성이 강한 유방암
세포주인 MDA-MB-231의 조건 배지(231 CM)를 처리한
암-연관 섬유아세포와 정상 유방 섬유아세포 내에서도
miR-4516 발현량이 감소되는 것이 보여졌다. 또한, 정상 유방
섬유아세포에 231 CM을 처리하였을 때 miR-4516 발현이
감소하며 암-연관 섬유아세포의 특징을 보였다. 암-연관
섬유아세포와 정상 유방 섬유아세포에서 각각 추출한
엑소좀을 유방암 세포주 MCF7과 MDA-MB-231에 처리 하였을
때, 유방암세포의 miR-4516의 발현이 암-연관 섬유아세포에서
유래된 엑소좀을 처리한 유방암세포에서는 거의 변화가
없었고 정상 유방 섬유아세포에서 유래된 엑소좀을 처리한
세포에서는 약 4배 이상 증가되어 존재함이 보여졌다. 또한, 
miR-4516을 MDA-MB-231과 MCF7에서 과발현 시켰을 때, 
종양진행과 관련된 유전자로 알려진 PHF8와 STAT3의 mRNA 
발현과 단백질 레벨이 감소하였다. 따라서 정상 유방
섬유아세포가 많이 옮기던 엑소좀 miR-4516가 종양세포의
지속적인 자극을 받아 암-연관 섬유아세포로 변하면서 발현이
감소되고 엑소좀을 통해 적게 옮겨지면서 유방암세포에
미치던 억제성 영향력이 줄어들어 종양진행에 긍정적 영향을
미칠 수 있다는 것을 보여준다.
핵심되는 말 : 엑소좀, 마이크로RNA, 암-연관 섬유아세포, 
종양미세환경, 유방암세포
